CARCINOMA, RENAL CELL

This study follows patients who are already taking the cancer drug belzutifan in earlier trials. Researchers want to understand the long-term survival benefits and safety of this medication for people with advanced solid tumors or tumors related to Von Hippel-Lindau disease. Only…

This study is testing a new medicine called PF-08634404 for adults with advanced kidney cancer that has spread. Researchers want to see if the medicine is safe and effective when given alone or with other cancer drugs. The study is recruiting 224 adults who haven't received any t…

This study is observing how well the drug vorolanib works and how safe it is for patients with advanced kidney cancer that has spread or cannot be removed by surgery. It involves 39 adults who are receiving vorolanib as their second treatment option. Researchers will track how lo…

This early-stage study is testing a drug called orellanine in people with advanced kidney cancer that has spread. The main goals are to find a safe dose and see if the drug can shrink tumors. The study is for patients who are already on regular dialysis and have run out of other …

This study is testing a new drug called BMS-986340 to see if it is safe and can help control advanced cancers. It will be given alone or combined with two other cancer drugs to about 950 people whose cancers have grown despite standard treatments. The main goal is to find the rig…

This study is testing a new artificial intelligence (AI) tool designed to automatically and accurately determine the stage of kidney cancer from a patient's CT scan. It will involve 1,000 people with confirmed kidney cancer to see if the AI can reliably tell if the cancer is at a…

This study is testing a new laboratory method to see if it can predict which cancer treatments will work best for a patient. Researchers will take a sample of a patient's tumor cells from a fluid or tissue biopsy and test how the cells react to different drugs in the lab. The goa…